ABCA3 Deficiency Presenting as Persistent Pulmonary Hypertension of the Newborn

Journal of Pediatrics

Volumn 151, Issue 3, 2007, Pages 322-324

  Kunig, Anette M ^a   Parker, Thomas A ^a   Nogee, Lawrence M ^b   Abman, Steven H ^a   Kinsella, John P ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b JOHNS HOPKINS CHILDREN S CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A3; ANTIBIOTIC AGENT; DOPAMINE; LUNG SURFACTANT; NITRIC OXIDE; UNCLASSIFIED DRUG;

AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; GAS EXCHANGE; GENE MUTATION; GENETIC ASSOCIATION; HEART SEPTUM DEFECT; HEMODYNAMICS; HOMOZYGOSITY; HOSPITALIZATION; HUMAN; HYPOXEMIA; INTUBATION; LUNG ARTERY PRESSURE; MALE; MISSENSE MUTATION; NEWBORN; OSCILLATION; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ATP-BINDING CASSETTE TRANSPORTERS; BRONCHODILATOR AGENTS; CHEST WALL OSCILLATION; FATAL OUTCOME; HUMANS; INFANT, NEWBORN; MALE; NITRIC OXIDE; PERSISTENT FETAL CIRCULATION SYNDROME; TREATMENT FAILURE;

EID: 34548015678     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.05.054     Document Type: Article

References (13)

1. Tryka A.F., Wert S.E., Mazursky J.E., Arrington R.W., and Nogee L.M. Absence of lamellar bodies with accumulation of dense bodies characterizes a novel form of congenital surfactant defect. Pediatr Dev Pathol 3 (2000) 335-345
2. Cutz E., Wert S.E., Nogee L.M., and Moore A.M. Deficiency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant. Am J Respir Crit Care Med 161 2 Pt 1 (2000) 608-614
3. Bullard J.E., Wert S.E., and Nogee L.M. ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. Semin Perinatol 30 (2006) 327-334
4. Bullard J.E., Wert S.E., Whitsett J.A., Dean M., and Nogee L.M. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 172 (2005) 1026-1031
5. Kinsella J.P., and Abman S.H. Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr 136 (2000) 717-726
6. Kinsella J.P., and Abman S.H. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126 (1995) 853-864
7. Walsh-Sukys M.C., Tyson J.E., Wright L.L., Bauer C.R., Korones S.B., Stevenson D.K., et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 105 1 Pt 1 (2000) 14-20
8. Fan L.L., Deterding R.R., and Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol 38 (2004) 369-378
9. Nogee L.M. Genetic mechanisms of surfactant deficiency. Biol Neonate 85 (2004) 314-318
10. Whitsett J.A., Wert S.E., and Trapnell B.C. Genetic disorders influencing lung formation and function at birth. Hum Mol Genet 13 Spec 2 (2004) R207-R215
11. Nagata K., Yamamoto A., Ban N., Tanaka A.R., Matsuo M., Kioka N., et al. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles. Biochem Biophys Res Commun 324 (2004) 262-268
12. Shulenin S., Nogee L.M., Annilo T., Wert S.E., Whitsett J.A., and Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 350 (2004) 1296-1303
13. Hallman M. Lung surfactant, respiratory failure, and genes. N Engl J Med 350 (2004) 1278-1280